脓毒症:当前概念和围手术期管理

M. Nunnally
{"title":"脓毒症:当前概念和围手术期管理","authors":"M. Nunnally","doi":"10.1097/ASA.0b013e31829a1d16","DOIUrl":null,"url":null,"abstract":"The syndrome sepsis embodies success and failure in modern medical care. Advances such as the development of antibiotics and organ support prevent immediate deaths from infection and organ dysfunction. However, patients with sepsis go on to develop critical illness and multiorgan system failure. Many still die. The result is that the population of patients with sepsis is sicker today than it was 50, or even 10, years ago. Mortality is effectively unchanged, whereas resource utilization increases. Each advance in therapy results in prolonged states of morbidity and unchanged mortalities. In 2005, an elderly patient with chronic obstructive pulmonary disease presenting to an intensive care unit with pneumonia and sepsis would have received a pneumococcal vaccine, an insulin infusion with the goal of ‘‘tight’’ glycemic control (i.e., serum glucose values between 80 and 110 mg/dL), and drotrecogin a (recombinant activated protein C), to disrupt a destructive inflammatory and coagulation cycle and improve end-organ perfusion. Just 7 years later, there is ample evidence to suggest that none of these therapies is helpful, and they may be harmful. Sepsis research has uncovered a complicated process of immune response to illness with broad systemic effects. We know more about the mechanisms that contribute to the syndrome, but efforts to block the response have been largely unsuccessful. Much of what we thought we knew about sepsis turned out to be wrong. With the exceptions of the control of the source of sepsis, timely antibiotics, and resuscitation, little has been discovered to improve outcomes in sepsis (Supplemental Digital Content 1, http://links.lww.com/ ASA/A321). Even these measures are subject to debate. The septic patient remains a therapeutic challenge. As professionals in perioperative medicine, anesthesia providers must be prepared to manage patients with sepsis syndrome. Timely and effective care is essential to the management of the septic patient and demands skills in resuscitation, monitoring, and operative management. For anyone practicing in the field of anesthesia and critical care, understanding sepsis is essential (Supplemental Digital Content 2,","PeriodicalId":91163,"journal":{"name":"Refresher courses in anesthesiology","volume":"41 1","pages":"95–102"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/ASA.0b013e31829a1d16","citationCount":"0","resultStr":"{\"title\":\"Sepsis: Current Concepts and Perioperative Management\",\"authors\":\"M. Nunnally\",\"doi\":\"10.1097/ASA.0b013e31829a1d16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The syndrome sepsis embodies success and failure in modern medical care. Advances such as the development of antibiotics and organ support prevent immediate deaths from infection and organ dysfunction. However, patients with sepsis go on to develop critical illness and multiorgan system failure. Many still die. The result is that the population of patients with sepsis is sicker today than it was 50, or even 10, years ago. Mortality is effectively unchanged, whereas resource utilization increases. Each advance in therapy results in prolonged states of morbidity and unchanged mortalities. In 2005, an elderly patient with chronic obstructive pulmonary disease presenting to an intensive care unit with pneumonia and sepsis would have received a pneumococcal vaccine, an insulin infusion with the goal of ‘‘tight’’ glycemic control (i.e., serum glucose values between 80 and 110 mg/dL), and drotrecogin a (recombinant activated protein C), to disrupt a destructive inflammatory and coagulation cycle and improve end-organ perfusion. Just 7 years later, there is ample evidence to suggest that none of these therapies is helpful, and they may be harmful. Sepsis research has uncovered a complicated process of immune response to illness with broad systemic effects. We know more about the mechanisms that contribute to the syndrome, but efforts to block the response have been largely unsuccessful. Much of what we thought we knew about sepsis turned out to be wrong. With the exceptions of the control of the source of sepsis, timely antibiotics, and resuscitation, little has been discovered to improve outcomes in sepsis (Supplemental Digital Content 1, http://links.lww.com/ ASA/A321). Even these measures are subject to debate. The septic patient remains a therapeutic challenge. As professionals in perioperative medicine, anesthesia providers must be prepared to manage patients with sepsis syndrome. Timely and effective care is essential to the management of the septic patient and demands skills in resuscitation, monitoring, and operative management. For anyone practicing in the field of anesthesia and critical care, understanding sepsis is essential (Supplemental Digital Content 2,\",\"PeriodicalId\":91163,\"journal\":{\"name\":\"Refresher courses in anesthesiology\",\"volume\":\"41 1\",\"pages\":\"95–102\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/ASA.0b013e31829a1d16\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Refresher courses in anesthesiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ASA.0b013e31829a1d16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Refresher courses in anesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ASA.0b013e31829a1d16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

脓毒症是现代医疗救治成功与失败的体现。抗生素和器官支持的发展等进步可防止因感染和器官功能障碍而立即死亡。然而,脓毒症患者会发展成危重疾病和多器官系统衰竭。许多人仍然死去。结果是,今天的败血症患者比50年前,甚至比10年前更严重。死亡率实际上没有变化,而资源利用率却在增加。治疗的每一项进展都导致发病率延长,死亡率不变。2005年,一位因肺炎和败血症而被送进重症监护病房的慢性阻塞性肺病老年患者接受了肺炎球菌疫苗、胰岛素输注,目的是“严格”控制血糖(即血清葡萄糖值在80 - 110 mg/dL之间),以及曲曲霉素a(重组活化蛋白C),以破坏破坏性炎症和凝血周期,改善终末器官灌注。仅仅7年后,有充分的证据表明,这些治疗方法都没有帮助,而且可能有害。脓毒症的研究揭示了一个复杂的免疫反应过程,对疾病有广泛的全身影响。我们对导致这种综合征的机制了解得更多,但阻止这种反应的努力在很大程度上是不成功的。我们对败血症的很多认识都是错误的。除了控制脓毒症的来源、及时使用抗生素和复苏外,几乎没有发现能改善脓毒症预后的措施(补充数字内容1,http://links.lww.com/ ASA/A321)。即便是这些措施也存在争议。脓毒症患者的治疗仍然是一个挑战。作为围手术期医学的专业人员,麻醉提供者必须准备好处理脓毒症综合征患者。及时有效的护理对脓毒症患者的管理至关重要,需要复苏、监护和手术管理方面的技能。对于任何在麻醉和重症监护领域工作的人来说,了解败血症是必不可少的(补充数字内容2,
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Sepsis: Current Concepts and Perioperative Management
The syndrome sepsis embodies success and failure in modern medical care. Advances such as the development of antibiotics and organ support prevent immediate deaths from infection and organ dysfunction. However, patients with sepsis go on to develop critical illness and multiorgan system failure. Many still die. The result is that the population of patients with sepsis is sicker today than it was 50, or even 10, years ago. Mortality is effectively unchanged, whereas resource utilization increases. Each advance in therapy results in prolonged states of morbidity and unchanged mortalities. In 2005, an elderly patient with chronic obstructive pulmonary disease presenting to an intensive care unit with pneumonia and sepsis would have received a pneumococcal vaccine, an insulin infusion with the goal of ‘‘tight’’ glycemic control (i.e., serum glucose values between 80 and 110 mg/dL), and drotrecogin a (recombinant activated protein C), to disrupt a destructive inflammatory and coagulation cycle and improve end-organ perfusion. Just 7 years later, there is ample evidence to suggest that none of these therapies is helpful, and they may be harmful. Sepsis research has uncovered a complicated process of immune response to illness with broad systemic effects. We know more about the mechanisms that contribute to the syndrome, but efforts to block the response have been largely unsuccessful. Much of what we thought we knew about sepsis turned out to be wrong. With the exceptions of the control of the source of sepsis, timely antibiotics, and resuscitation, little has been discovered to improve outcomes in sepsis (Supplemental Digital Content 1, http://links.lww.com/ ASA/A321). Even these measures are subject to debate. The septic patient remains a therapeutic challenge. As professionals in perioperative medicine, anesthesia providers must be prepared to manage patients with sepsis syndrome. Timely and effective care is essential to the management of the septic patient and demands skills in resuscitation, monitoring, and operative management. For anyone practicing in the field of anesthesia and critical care, understanding sepsis is essential (Supplemental Digital Content 2,
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信